National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA.
Acc Chem Res. 2011 Oct 18;44(10):883-92. doi: 10.1021/ar200044b. Epub 2011 May 6.
Enormous efforts have been made toward the translation of nanotechnology into medical practice, including cancer management. Generally the applications have fallen into two categories: diagnosis and therapy. Because the targets are often the same, the development of separate approaches can miss opportunities to improve efficiency and effectiveness. The unique physical properties of nanomaterials enable them to serve as the basis for superior imaging probes to locate and report cancerous lesions and as vehicles to deliver therapeutics preferentially to those lesions. These technologies for probes and vehicles have converged in the current efforts to develop nanotheranostics, nanoplatforms with both imaging and therapeutic functionalities. These new multimodal platforms are highly versatile and valuable components of the emerging trend toward personalized medicine, which emphasizes tailoring treatments to the biology of individual patients to optimize outcomes. The close coupling of imaging and treatment within a theranostic agent and the data about the evolving course of an illness that these agents provide can facilitate informed decisions about modifications to treatment. Magnetic nanoparticles, especially superparamagnetic iron oxide nanoparticles (IONPs), have long been studied as contrast agents for magnetic resonance imaging (MRI). Owing to recent progress in synthesis and surface modification, many new avenues have opened for this class of biomaterials. Such nanoparticles are not merely tiny magnetic crystals, but potential platforms with large surface-to-volume ratios. By taking advantage of the well-developed surface chemistry of these materials, researchers can load a wide range of functionalities, such as targeting, imaging and therapeutic features, onto their surfaces. This versatility makes magnetic nanoparticles excellent scaffolds for the construction of theranostic agents, and many efforts have been launched toward this goal. In this Account, we introduce the surface engineering techniques that we and others have developed, with an emphasis on how these techniques affect the role of nanoparticles as imaging or therapeutic agents. We and others have developed a set of chemical methods to prepare magnetic nanoparticles that possess accurate sizes, shapes, compositions, magnetizations, relaxivities, and surface charges. These features, in turn, can be harnessed to adjust the toxicity and stability of the nanoparticles and, further, to load functionalities, via various mechanisms, onto the nanoparticle surfaces.
人们在将纳米技术应用于医学实践,包括癌症治疗方面付出了巨大努力。一般来说,这些应用主要分为两类:诊断和治疗。由于目标往往是相同的,因此分别开发的方法可能会错失提高效率和效果的机会。纳米材料的独特物理特性使它们能够成为优越的成像探针的基础,以定位和报告癌性病变,并作为将治疗药物优先递送到这些病变部位的载体。这些探针和载体技术在当前开发纳米治疗学的努力中已经融合,纳米治疗学是具有成像和治疗功能的纳米平台。这些新的多模态平台是新兴个性化医疗趋势的高度通用和有价值的组成部分,个性化医疗强调根据个体患者的生物学来定制治疗方法,以优化治疗效果。治疗剂中成像和治疗的紧密结合以及这些治疗剂提供的疾病进展数据,可以促进有关治疗方法修改的明智决策。磁性纳米粒子,特别是超顺磁氧化铁纳米粒子(IONP),长期以来一直被研究作为磁共振成像(MRI)的对比剂。由于合成和表面修饰方面的最新进展,为这类生物材料开辟了许多新途径。这些纳米粒子不仅仅是微小的磁性晶体,而是具有大的表面积与体积比的潜在平台。通过利用这些材料发达的表面化学,研究人员可以将广泛的功能(如靶向、成像和治疗功能)加载到它们的表面。这种多功能性使磁性纳米粒子成为治疗剂构建的理想支架,并且已经为此做出了许多努力。在本述评中,我们介绍了我们和其他人开发的表面工程技术,重点介绍了这些技术如何影响纳米粒子作为成像或治疗剂的作用。我们和其他人开发了一系列化学方法来制备具有准确尺寸、形状、组成、磁化强度、弛豫率和表面电荷的磁性纳米粒子。这些特性反过来又可以用于调整纳米粒子的毒性和稳定性,并且可以通过各种机制进一步将功能加载到纳米粒子表面。